桑葉中のアザ糖の体内動態の評価・解明

[1] J.-L. Chiasson et al., “Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial,” Lancet, vol. 359, no. 9323, pp. 2072–2077, 2002

[2] R. Kawamori et al., “Voglibose for prevention of type 2 diabetes mellitus: a randomised, double- blind trial in Japanese individuals with impaired glucose tolerance,” Lancet, vol. 373, no. 9675, pp. 1607–1614, 2009

[3] I. S. Parida et al., “Supplementation of Bacillus amyloliquefaciens AS385 culture broth powder containing 1-deoxynojirimycin in a high-fat diet altered the gene expressions related to lipid metabolism and insulin signaling in mice epididymal white adipose tissue,” Food Funct., vol. 11, no. 5, pp. 3926–3940, 2020

[4] S. E et al., “Intake of mulberry 1-deoxynojirimycin prevents colorectal cancer in mice,” J. Clin. Biochem. Nutr., vol. 61, no. 1, pp. 16–94, 2017

[5] W. Chen et al., “Neuroprotective effect of 1-Deoxynojirimycin on cognitive impairment, β- amyloid deposition, and neuroinflammation in the SAMP8 mice,” Biomed. Pharmacother., vol. 106, pp. 92–97, 2018

[6] N. Asano et al., “Polyhydroxylated Alkaloids Isolated from Mulberry Trees ( Morus alba L.) and Silkworms ( Bombyx mori L.),” J. Agr. Food Chem., vol. 49, no. 9, pp. 4208–4213, 2001

[7] D. C. Stein, L. K. Kopec, R. E. Yasbin, and F. E. Young, “Characterization of Bacillus subtilis DSM704 and its production of 1-deoxynojirimycin,” Appl. Environ. Microbiol., vol. 48, no. 2, pp. 280–284, 1984

[8] N. Ishida, K. Kumagai, T. Niida, T. Tsuruoka, and H. Yumoto, “Nojirimycin, a new antibiotic. II. Isolation, characterization and biological activity.,” J. Antibiotics, vol. 20, no. 2, pp. 66–71, 1967.

[9] S. Yang et al., “Pharmacokinetics, Tissue Distribution, and Elimination of Three Active Alkaloids in Rats after Oral Administration of the Effective Fraction of Alkaloids from Ramulus Mori, an Innovative Hypoglycemic Agent,” Molecules, vol. 22, no. 10, p. 1616, 2017

[10] S. Amézqueta, S. Ramos-Romero, C. Martínez-Guimet, A. Moreno, M. Hereu, and J. L. Torres, “Fate of d -Fagomine after Oral Administration to Rats,” J. Agr. Food Chem., vol. 65, no. 22, pp. 4414–4420, 2017

[11] K. Nakagawa et al., “Occurrence of Orally Administered Mulberry 1-Deoxynojirimycin in Rat Plasma,” J. Agr. Food Chem., vol. 55, no. 22, pp. 8928–8933, 2007

[12] T. Liang et al., “A UPLC–MS/MS method for simultaneous determination of 1- deoxynojirimycin and N-methyl-1-deoxynojirimycin in rat plasma and its application in pharmacokinetic and absolute bioavailability studies,” J. Chromatogr. B, vol. 1072, 2017, pp. 205– 210, 2018

[13] T. Tsuduki et al., “Intake of 1-Deoxynojirimycin Suppresses Lipid Accumulation through Activation of the β-Oxidation System in Rat Liver,” J. Agr. Food Chem., vol. 57, no. 22, pp. 11024– 11029, 2009

[14] M. Kimura, F.-J. Chen, N. Nakashima, I. Kimura, N. Asano, and S. Koya, “Antihyperglycemic effects of N-containing sugars derived from mulberry leaves in streptozocin-induced diabetic mice,” J. Trad. Med., vol. 12, pp. 214–219, 1995

[15] S. Takasu et al., “Intestinal Absorption and Tissue Distribution of Aza-Sugars from Mulberry Leaves and Evaluation of Their Transport by Sugar Transporters,” J. Agr. Food Chem., vol. 68, no. 24, pp. 6656–6663, 2020

[16] A. Mizuno-Yasuhira et al., “A Strategy for Assessing Potential Drug-Drug Interactions of a Concomitant Agent against a Drug Absorbed via an Intestinal Transporter in Humans,” Drug Metab. Dispos., vol. 42, no. 9, pp. 1456–1465, 2014

[17] K. Yamagishi et al., “Lactose Increases the Production of 1-deoxynojirimycin in Bacillus amyloliquefaciens,” Food Sci. Technol. Res., vol. 23, no. 2, pp. 349–353, 2017

[18] 高須蒼生, 木村俊之, 伊藤隼哉, and 仲川清隆, “第 13 回農芸化学研究企画賞 食後高血糖改善成分を含む新規食材の活用: 桑葉・微生物による DNJ の生産と機能性・安全性の評価,”化学と生物, vol. 58, no. 1, pp. 13–19, 2020